Parkinsons
14
4
5
2
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
7.1%
1 terminated out of 14 trials
66.7%
-19.9% vs benchmark
7%
1 trials in Phase 3/4
100%
2 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (14)
Multimodal Tracking of Therapy Activity and Effort During Rehabilitation
Investigations of Dementia in Parkinson Disease
Molecular and Functional Imaging in Monogenic PD.
Longitudinal Investigation of I2BS in PD
Serotonin Release in Premotor and Motor PD
Quality Improvement and Practice Based Research in Neurology Using the EMR
Evaluating the Efficacy and Safety of PROSOMNIA Sleep Therapy™ in Patients With Sleep Deprivation and Chronic Insomnia
Light Therapy Plus Exercise to Improve Motor, Non-Motor Symptoms and QoL in Parkinson's Disease
Cognitive Dysfunction In Parkinson's
Lack of Awareness of Symptoms (Anosognosia) in PD: An Observational Study for People With Parkinson's
tDCS in Parkinson's Disease With Depression
Sound Estimation and Accuracy Task
Nurse Management of Neuromodulation Therapy
Apolipoprotein D (ApoD) In Human Serum As Marker Of Parkinson's Disease